Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
If you dont lose at least 10% of your bodyweight in the first 4 months, well refund every penny.
Journal Articles Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth ( Journal of Orthopaedic Research ) Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing ( Cell and Tissue Research ) Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway ( Scientific Research ) Stable Gastric Pentadecapeptide BPC 157 and Wound Healing ( Frontiers in Pharmacology ) Insulin-like growth factor 1 (IGF-1): a growth hormone ( Molecular Pathology ) MK-677, an Orally Active Growth Hormone Secretagogue, Reverses Diet-Induced Catabolism ( The Journal of Clinical Endocrinology & Metabolism ) Two-Month Treatment of Obese Subjects with the Oral Growth Hormone (GH) Secretagogue MK-677 Increases GH Secretion, Fat-Free Mass, and Energy Expenditure ( The Journal of Clinical Endocrinology & Metabolism ) Kisspeptin signalling and its roles in humans ( Singapore Med J ) Age-Related Changes of the Pineal Gland in Humans: A Digital Anatomo-Histological Morphometric Study on Autopsy Cases with Comparison to Predigital-Era Studies ( Medicina ) Huberman Lab Episodes Mentioned This transcript is currently under human review and may contain errors
doi:10.1016/S0140-6736(23)01053-X PubMed: This trial evaluated retatrutide in 281 participants with type 2 diabetes, showing up to 16.94% weight loss and significant HbA1c reductions with favorable safety profile comparable to other GLP-1 based therapies
Sikiric P, Seiwerth S, Rucman R, Turkovic B, Rokotov DS, Brcic L, Sever M
Note: The above statements have not been evaluated by the Food and Drug Administration
